Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation
Multiple sclerosis (MS) is an autoimmune inflammatory disease characterized by demyelination, axonal loss, and synaptic impairment in the central nervous system (CNS). The available therapies aim to reduce the severity of the pathology during the early inflammatory stages, but they are not effective...
Main Authors: | Alessandra Roggeri, Melissa Schepers, Assia Tiane, Ben Rombaut, Lieve van Veggel, Niels Hellings, Jos Prickaerts, Anna Pittaluga, Tim Vanmierlo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/20/7537 |
Similar Items
-
From OPC to Oligodendrocyte: An Epigenetic Journey
by: Assia Tiane, et al.
Published: (2019-10-01) -
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
by: Davin Packer, et al.
Published: (2023-06-01) -
Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis
by: Elisabeth Traiffort, et al.
Published: (2021-03-01) -
Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination
by: Mohammad Abu-Rub, et al.
Published: (2018-06-01) -
Oligodendroglial primary cilium heterogeneity during development and demyelination/remyelination
by: Giada Delfino, et al.
Published: (2022-11-01)